Triple
T18386479
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Merck KGaA global headquarters |
E446604
|
entity |
| Predicate | hasDepartment |
P35
|
FINISHED |
| Object | investor relations department of Merck KGaA |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: investor relations department of Merck KGaA | Statement: [Merck KGaA global headquarters, hasDepartment, investor relations department of Merck KGaA]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: investor relations department of Merck KGaA Context triple: [Merck KGaA global headquarters, hasDepartment, investor relations department of Merck KGaA]
-
A.
Merck Life Science
Merck Life Science is the life science business of Merck KGaA, providing products and technologies for research, biotechnology, and pharmaceutical development worldwide.
-
B.
Merck KGaA global headquarters
Merck KGaA global headquarters is the central corporate and administrative hub of the multinational science and technology company Merck KGaA.
-
C.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
D.
Office of Capital Markets
The Office of Capital Markets is a U.S. Treasury Department unit that oversees and advises on policies affecting financial markets, securities, and capital formation.
-
E.
Capital Markets Bureau
The Capital Markets Bureau is a division of South Korea’s financial regulator responsible for overseeing and developing policies for the nation’s capital markets and securities industry.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: investor relations department of Merck KGaA Target entity description: The investor relations department of Merck KGaA is the corporate unit responsible for managing communication and relationships between the company’s global headquarters and its shareholders, analysts, and the broader financial community.
-
A.
Merck Life Science
Merck Life Science is the life science business of Merck KGaA, providing products and technologies for research, biotechnology, and pharmaceutical development worldwide.
-
B.
Merck KGaA global headquarters
Merck KGaA global headquarters is the central corporate and administrative hub of the multinational science and technology company Merck KGaA.
-
C.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
D.
Office of Capital Markets
The Office of Capital Markets is a U.S. Treasury Department unit that oversees and advises on policies affecting financial markets, securities, and capital formation.
-
E.
Capital Markets Bureau
The Capital Markets Bureau is a division of South Korea’s financial regulator responsible for overseeing and developing policies for the nation’s capital markets and securities industry.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8b9f370b88190b1e5081c2c238e7f |
completed | April 10, 2026, 8:50 a.m. |
| NER | Named-entity recognition | batch_69e517a00c608190a8f0010c7b53df90 |
completed | April 19, 2026, 5:57 p.m. |
Created at: April 10, 2026, 10:46 a.m.